Advertisement

Topics

The Society of Memorial Sloan-Kettering Cancer Center Company Profile

23:02 EST 21st November 2017 | BioPortfolio


News Articles [4096 Associated News Articles listed on BioPortfolio]

Juno licenses immuno-oncology IP from Memorial Sloan Kettering

Juno Therapeutics Inc. (oncology immunotherapy start-up) has launched with exclusive global rights to intellectual property from Memorial Sloan Kettering Cancer Center.

Y-mAbs licenses exclusive immunotherapy rights from Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center granted Y-mAbs Therapeutics Inc. exclusive global rights to two clinical-stage fully humanized antibodies and non-exclusive access to the MULTI-TAG protein multi...

2017 Paul Marks Prize for Cancer Research goes to Young Investigators (under 45) named by Memorial Sloan Kettering (MSK)

2017 Paul Marks Prize for Cancer Research goes to Young Investigators (under 45) named by Memorial Sloan Kettering (MSK)   Reporter: Aviva Lev-Ari, PhD, RN   The winners are Gad (Gaddy) Get...

Memorial Sloan Kettering and Cota want to use data to advance cancer treatment

The two New York City-based organizations have partnered on an initiative aimed at precision oncology research and treatment. By leveraging Cota’s classification system, Memorial Sloan Ketterin...

GIST tumours linked to NF1 mutations, genetic testing needed

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, ca...

Going nano in the fight against cancer

Imagine being able to see the signs of cancer decades before we can now. URI Chemical Engineering Assistant Professor Daniel Roxbury and researchers from Memorial Sloan Kettering Cancer Center have in...

GIST tumors linked to NF1 mutations, genetic testing needed

(University of California - San Diego) Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a...

Epigenetic Code Plays a Role in Leukemia

Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment strategies, according to a new study by scientists from ...

PubMed Articles [8082 Associated PubMed Articles listed on BioPortfolio]

The Tri-Institutional Pain Registry-Analysis of Outpatient Pain Management at a Specialized Cancer Center.

The Outpatient Pain Clinics at Memorial Sloan Kettering Cancer Center participated in developing a pain registry to gain insight on the referral and management of cancer pain as related to demographic...

Value Tools in Managed Care Decision Making: Current Hurdles and Future Opportunities.

Organizations such as the National Comprehensive Cancer Network, American Society of Clinical Oncology, Institute for Clinical and Economic Review, and Memorial Sloan Kettering have created distinct t...

Value-Based Calculators in Cancer: Current State and Challenges.

The ASCO Value Framework, National Comprehensive Cancer Network Evidence Blocks, Memorial Sloan Kettering's DrugAbacus, and Institute for Clinical and Economic Review incremental cost-effectiveness ra...

South Asian Health. From Research to Practice and Policy: An Overview.

The US South Asian population has grown tremendously, and is now over 2.5 million. South Asians often face tremendous cultural, socioeconomic, linguistic and structural obstacles to good health, and f...

Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.

Rivaroxaban is broadly used for the primary prevention of stroke and systemic embolism in the general population with nonvalvular atrial fibrillation (AF). However, there is little published evidence ...

Clinical Trials [8834 Associated Clinical Trials listed on BioPortfolio]

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes...

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

With a major liver or pancreas operation, there is a chance that one will require a transfusion of blood products (either red blood cells or plasma). This may be necessary during the oper...

A Randomized Study of Sulindac in Oral Premalignant Lesions

The purpose of this study is to see if a drug called sulindac can prevent the development of changes in the mouth that are related to oral pre-cancer growths (oral epithelial dysplasia) or...

Behavioral Intervention For BMT/SCT Survivors

The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type...

Companies [3355 Associated Companies listed on BioPortfolio]

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center's tradition of care began more than 100 years ago. In 1884, the cornerstone of the New York Cancer Hospital -- what was later to become Memorial Hospital for Can...

The Society of Memorial Sloan-Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

The CMO’s Structure, Assets, and Goals

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial infecti...

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Me...

More Information about "The Society of Memorial Sloan-Kettering Cancer Center" on BioPortfolio

We have published hundreds of The Society of Memorial Sloan-Kettering Cancer Center news stories on BioPortfolio along with dozens of The Society of Memorial Sloan-Kettering Cancer Center Clinical Trials and PubMed Articles about The Society of Memorial Sloan-Kettering Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Society of Memorial Sloan-Kettering Cancer Center Companies in our database. You can also find out about relevant The Society of Memorial Sloan-Kettering Cancer Center Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record